VEGFA and neoplasm: Conversely, bevacizumab acts as a vascular endothelial growth factor (VEGF) inhibitor, effectively suppressing tumor angiogenesis, a pivotal process that facilitates the provision of nutrients and oxygen to the tumor, thereby promoting its dissemination.